Current Status of Drug Delivery to Tumors: Determinants, Challenges, and Opportunities Clinton Stewart, Pharm.D., FAAPS – St. Jude Children's Research Hospital
3:30 PM - 4:00 PM
PBPK Model Based Drug Development to Support Formulation and Dose Regimen Selections for Cutaneous Topical Drugs Laurence Del Frari, Pharm.D. – Pierre Fabre Laboratories
4:00 PM - 4:30 PM
Challenges in the Development of Pharmacotherapies for NAFLD/NASH Kyunghee Yang, Ph.D. – DILIsym Services Inc.
4:30 PM - 5:00 PM
Drug Properties + CNS PBPK Model = Prediction of Drug PK Profiles in Multiple CNS Compartments Elizabeth C. de Lange, PhD, FAAPS – Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden U